| Financial Year |
March 31 2023 |
| Monetary Funds |
181,963,721.91 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
34,333,320.99 |
| Accounts Receivable |
147,042,132.94 |
| Advances to Suppliers |
13,119,524.97 |
| Other Receivables |
4,377,315.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
83,437,743.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,742,940.13 |
| Total Current Assets |
548,050,880.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,439,013.52 |
| Investment Properties |
-- |
| Fixed Assetes |
200,108,861.61 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,895,913.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,214,302.38 |
| Other Non-Current Assets |
1,482,000.00 |
| Sub-Total of Non-Current Assets |
283,140,090.77 |
| Total Assets |
831,190,971.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
16,719,044.80 |
| Accounts Received In Advance |
112,293.57 |
| Employee Compensation Payable |
2,864,556.96 |
| Taxes Payable |
6,819,071.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,451,712.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,660,237.55 |
| Sub-Total of Current Liabilities |
55,332,590.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,746,735.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,254,397.84 |
| Total Liabilities |
90,586,988.18 |
| Paid-In Capital(Or Share Stock) |
507,509,848.00 |
| Capital Surplus |
123,406,532.58 |
| Surplus Reserve |
27,223,004.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
82,464,598.37 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
740,603,983.55 |
| Owner's Equity（Stockholder's Equity） |
740,603,983.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
831,190,971.73 |
